Adjuvant Chemotherapy in Resectable Cholangiocarcinoma Patients

Kosin Wirasorn; Thundon Ngamprasertchai; Narong Khuntikeo; Ake Pakkhem; Piti Ungarereevittaya; Jarin Chindaprasirt; Aumkhae Sookprasert

Disclosures

J Gastroenterol Hepatol. 2013;28(12):1885-1891. 

In This Article

Conclusions

AC significantly prolongs survival time in resectable cholangiocarcinoma patients, particularly the high-risk group. A further prospective randomized control trial should be done to confirm benefits.

processing....